<DOC>
	<DOC>NCT02797847</DOC>
	<brief_summary>The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of ALN-TTRSC02 in healthy subjects.</brief_summary>
	<brief_title>A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Amyloidosis</mesh_term>
	<criteria>Male and female subjects, age 18 to 65 years, inclusive. Body mass index (BMI) ≥18.0 kg/m2 and ≤30 kg/m2 assessed at Screening. No clinically significant health concerns, as determined by medical history and physical examination, in the opinion of the Investigator. Women of child bearing potential must have a negative pregnancy test, cannot be breastfeeding, and must be willing to use contraception, willing and able to comply with the study requirements and to provide written informed consent. For Japanese cohorts, subjects of Japanese descent are defined as people carrying a Japanese passport, descendants of 4 Japanese grandparents, and have not been outside Japan for more than 5 years. Clinically relevant history or presence of respiratory, gastrointestinal, renal, cardiovascular, hepatic, hematological, lymphatic, neurological, psychiatric, musculoskeletal, genitourinary, immunological, and other inflammatory diseases, or dermatological or connective tissue diseases or disorders. Active serious mental illness or psychiatric disorder. Clinically significant ECG abnormalities. Abnormal for AST/ALT and any other clinical safety laboratory result considered clinically significant. Known history of allergic reaction to an oligonucleotide or GalNAc. History of intolerance to subcutaneous injection.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>TTR-mediated Amyloidosis</keyword>
	<keyword>Amyloidosis, Hereditary</keyword>
	<keyword>Amyloid Neuropathies, Familial</keyword>
	<keyword>Familial Amyloid Polyneuropathies</keyword>
	<keyword>Amyloid Neuropathies</keyword>
	<keyword>Amyloidosis, Hereditary, Transthyretin-Related</keyword>
	<keyword>Familial Amyloidosis</keyword>
	<keyword>RNAi therapeutic</keyword>
</DOC>